Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (71-80 of 333) with videos related to

Pageof 34
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2020
New applications for independent activities of daily living in measuring disability in multiple sclerosisAmber Salter, Robert J Fox, Tuula Tyry, et al.
Multiple Sclerosis and Related Disorders|May 8, 2019
The association of fatigue and social participation in multiple sclerosis as assessed using two different instrumentsAmber Salter, Robert J Fox, Tuula Tyry, et al.
Journal of the Neurological Sciences|April 2, 2026
Clocks out of sync: Increased epigenetic aging variability in multiple sclerosisFernanda L Schumacher, Gary Cutter, Christin E Burd, et al.
Multiple Sclerosis and Related Disorders|March 20, 2026
Beyond the 2024 McDonald criteria for defining and diagnosing multiple sclerosisGavin Giovannoni, Edward J Thompson, Gary Cutter, et al.
Multiple Sclerosis and Related Disorders|May 19, 2024
Association of patient-reported cognitive impairment with quality of life and employment in multiple sclerosisSamantha Lancia, Ruth Ann Marrie, Gary Cutter, et al.
Annals of the New York Academy of Sciences|October 25, 2017
Learning from the past: reflections on recently completed myasthenia gravis trialsMichael Benatar, James F Howard, Richard Barohn, et al.
Pain|September 5, 2006
Persistent pain and uncomfortable sensations in persons with multiple sclerosisOlympia Hadjimichael, Robert D Kerns, Marco A Rizzo, et al.
Clinical Therapeutics|August 22, 2012
Long-term cost-effectiveness model of interferon beta-1b in the early treatment of multiple sclerosis in the United StatesFeng Pan, Jo Wern Goh, Gary Cutter, et al.
Neurology. Clinical Practice|November 16, 2022
Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple SclerosisYinan Zhang, Stacey Cofield, Gary Cutter, et al.
Rheumatology (Oxford, England)|April 11, 2021
Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trialSusan L Murphy, Mary Barber, Suiyuan Huang, et al.
Pageof 34

Showing results (71-80 of 333) with videos related to

Sort By:
Pageof 34
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2020
New applications for independent activities of daily living in measuring disability in multiple sclerosisAmber Salter, Robert J Fox, Tuula Tyry, et al.
Multiple Sclerosis and Related Disorders|May 8, 2019
The association of fatigue and social participation in multiple sclerosis as assessed using two different instrumentsAmber Salter, Robert J Fox, Tuula Tyry, et al.
Journal of the Neurological Sciences|April 2, 2026
Clocks out of sync: Increased epigenetic aging variability in multiple sclerosisFernanda L Schumacher, Gary Cutter, Christin E Burd, et al.
Multiple Sclerosis and Related Disorders|March 20, 2026
Beyond the 2024 McDonald criteria for defining and diagnosing multiple sclerosisGavin Giovannoni, Edward J Thompson, Gary Cutter, et al.
Multiple Sclerosis and Related Disorders|May 19, 2024
Association of patient-reported cognitive impairment with quality of life and employment in multiple sclerosisSamantha Lancia, Ruth Ann Marrie, Gary Cutter, et al.
Annals of the New York Academy of Sciences|October 25, 2017
Learning from the past: reflections on recently completed myasthenia gravis trialsMichael Benatar, James F Howard, Richard Barohn, et al.
Pain|September 5, 2006
Persistent pain and uncomfortable sensations in persons with multiple sclerosisOlympia Hadjimichael, Robert D Kerns, Marco A Rizzo, et al.
Clinical Therapeutics|August 22, 2012
Long-term cost-effectiveness model of interferon beta-1b in the early treatment of multiple sclerosis in the United StatesFeng Pan, Jo Wern Goh, Gary Cutter, et al.
Neurology. Clinical Practice|November 16, 2022
Predictors of Disease Activity and Worsening in Relapsing-Remitting Multiple SclerosisYinan Zhang, Stacey Cofield, Gary Cutter, et al.
Rheumatology (Oxford, England)|April 11, 2021
Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trialSusan L Murphy, Mary Barber, Suiyuan Huang, et al.
Pageof 34